ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1432	National Cancer Institute	Html	en	Childhood Extracranial Germ Cell Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood extracranial germ cell tumors.	high-risk malignant germ 0.382627 germ cell tumor 0.468475 testicular germ cell 0.429106 children 0.370996 nonseminomatous germ cell 0.393341 germ cell tumours 0.41986 Perlman EJ 0.354009 metastatic germ cell 0.400721 Cancer Group 0.365469 Cancer Res 0.351158 German germ cell 0.402914 ovarian malignant germ 0.383572 International Germ Cell 0.398303 childhood endodermal sinus 0.354399 malignant extracranial germ 0.38557 extragonadal germ cell 0.411876 Germ Cell Cancer 0.403131 Pediatric malignant germ 0.402466 childhood cancer 0.363851 eighty-one pediatric germ 0.390298 mediastinal germ cell 0.418591 sacrococcygeal germ cell 0.389319 pediatric germ cell 0.545311 et al. 0.455659	germ cell neoplasms 0.392505 childhood cancer mortality 0.358219 Cancer Genet Cytogenet 0.354846 extracranial germ cell 0.411151 ovarian germ cell 0.394977 United States 0.356408 poor-prognosis metastatic germ 0.37618 Germ Cell Consensus 0.387357 PUBMED Abstract 0.47974 Pediatric Oncology Group/Children 0.350706 Genes Chromosomes Cancer 0.370613 malignant germ cell 0.446287 Clin Oncol 0.410768 adolescent cancer survivors 0.362753 endodermal sinus tumors 0.380924 Schneider DT 0.373974 male germ cell 0.395998 germ cell tumors 0.95816 gonadal tumors 0.362307 primary germ cell 0.419689 cancer 0.42182 pediatric oncology group 0.391354 childhood germ cell 0.423704 germ cell cancers 0.387284	CLICK HERE
1646	National Cancer Institute	Html	en	Cancer Screening Overview (PDQ®)–Patient Version	Information about measuring the effectiveness of cancer screening tests and about weighing the strength of the evidence obtained from cancer screening research studies.	new screening test 0.617185 health care provider 0.670679 odds ratio 0.601994 PDQ cancer information 0.657991 clinical trials 0.728892 cervical cancer rates 0.56941 test result 0.575182 cancer information summary 0.627344 group 0.594884 clinical trial 0.572791 test results 0.625142 breast cancer prevention 0.567805 cancer patients 0.585953 PDQ® Screening 0.567153 cancer risk factor 0.586088 cervical cancer 0.569926 relative risk 0.572167 symptoms 0.56993 cancer symptoms 0.5675 NCI PDQ cancer 0.589008 accurate cancer screening 0.616077 useful cancer screening 0.649307 PDQ Screening 0.5802 Cancer Information Service 0.580898	useful screening test 0.597804 Prevention Editorial Board 0.577411 certain disease 0.568589 National Cancer Institute 0.720252 studies 0.621784 certain gene mutations 0.593801 Screening trials 0.573937 Cancer Care page 0.570337 breast cancer 0.60178 people 0.685308 absolute risk 0.574938 standard screening test 0.598763 survival time 0.567302 screening test 0.737252 cancer screening tests 0.703056 cancer information summaries 0.578991 screening procedures 0.580721 comprehensive cancer information 0.579656 long cancer patients 0.576239 screening mammogram 0.574868 cancer 0.928642 information 0.71123 risk 0.62101 research studies 0.609116	CLICK HERE
1885	National Cancer Institute	Html	es	Tratamiento de los cánceres poco comunes en la niñez (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los cánceres poco comunes en la niñez como los cánceres de la cabeza y el cuello, el tórax, el abdomen, el aparato reproductor, la piel y otros.	Group Childhood Cancer 0.303634 Kadish Estadio Descripción 0.300271 cancer statistics 0.326488 pediatric rare tumors 0.992234 patients with relapsed 0.372754 cuadro clínico 0.354432 Advanced Solid Tumors 0.370423 estadificación posoperatoria 0.711901 GPOH Pediatric Rare 0.343984 cooperative study group 0.363939 Sin embargo 0.560837 ATA Task Force 0.473736 Pediatric Patients with 0.461297 Childhood Cancer Research 0.442875 cuáles pacientes 0.308117 Targeted Therapy Directed 0.368386 Treating Pediatric Patients 0.460472 or histiocytic disorders 0.361605 Internet ClinicalTrials.gov 0.45578 metástasis distantes 0.307395 Children's Oncology Group 0.570172 niños vs 0.418573 International Classification 0.392171 or refractory advanced 0.367754 tiroides medular nem2 0.365237	very rare tumors 0.299588 Refractory Advanced Solid 0.36854 carcinoma nasofaríngeo 0.834137 Pediatric Molecular Analysis 0.447293 Pediatric MATCH 0.923242 pediatric thyroid cancer 0.456559 End Results 0.382399 gammagrafía ósea 0.326636 BRAF V600E 0.354329 Childhood Cancer 0.803535 relapsed or refractory 0.373353 efectos tardíos 0.368787 ATA Pediatric Risk 0.307191 menudo metástasis 0.316315 Riesgo pediátrico intermedio 0.363674 rare pediatric tumors 0.355894 PDQ Tratamiento 0.348659 mutaciones braf v600e 0.349145 NCI-COG Pediatric Molecular 0.449773 gammagrafía diagnóstica 0.608069 Clin Oncol 0.421865 subgrupo xi 0.374046 with relapsed or 0.368469 european cooperative study 0.370036	CLICK HERE
1984	National Cancer Institute	Html	es	Cuidados médicos de apoyo en niños (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de la peculiaridad de los asuntos que surgen durante y después del tratamiento en los niños con cáncer y como sobrevivientes adultos de cáncer.	among adult survivors 0.308012 Dev Behav Pediatr 0.311435 Last BF 0.307728 randomized controlled trials 0.307154 childhood cancer survivors 0.686811 Arch Gen Psychiatry 0.307642 largo plazo 0.386463 American Cancer Society 0.324849 Child Adolesc Psychiatry 0.308067 posttraumatic stress symptoms 0.324331 health-related quality 0.319663 Child Health Care 0.307161 adult survivors 0.332882 Hobbie WL 0.307769 suicidal ideation 0.309111 Pediatr Psychol 0.406392 stress symptoms during 0.307126 Health Care 0.307239 Grootenhuis MA 0.307795 Pediatr Nurs 0.308601 childhood cancer 0.948281 cancer survivor study 0.418789 células madre 0.316714 young adult survivors 0.314912 Phipps S 0.31239	adultos jóvenes 0.324674 Cancer Suppl 0.320779 Children’s Oncology Group 0.311705 leucemia linfoblástica aguda 0.307137 Cancer Facts 0.31467 posttraumatic stress 0.424392 Pediatr Blood Cancer 0.341708 sobrevivientes adultos 0.315742 efectos tardíos 0.308299 report from 0.327686 childhood leukemia 0.320175 during treatment 0.3081 Pediatr Oncol Nurs 0.312201 children with 0.442277 bone marrow transplant 0.30728 Pediatr Oncol 0.312328 Pediatr Hematol Oncol 0.312789 Clin Oncol 0.319255 sistema nervioso central 0.312739 tensión traumática 0.309229 Zebrack BJ 0.312471 surviving childhood 0.31989 Gartstein MA 0.308683 Zeltzer LK 0.312906	CLICK HERE
2034	National Cancer Institute	Html	es	Exámenes de detección del cáncer de próstata (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de los factores que pueden influir en el desarrollo del cáncer de próstata y sobre la investigación dirigida a la prevención de esta enfermedad.	Visuals Online 0.517288 hiperplasia prostática benigna 0.934751 PDQ Exámenes 0.558681 Physician Data Query 0.625171 Estados Unidos 0.627104 prevención revisa 0.522163 sistema urinario masculino 0.572586 PDQ Prevención 0.600306	largo plazo 0.529195 aparato reproductor masculino 0.57627 información ayuda 0.525906 National Cancer Institute 0.530649 semen.ampliar anatomía 0.542589 siguientes riesgos 0.520738 siguientes sumarios 0.573516 Instituto Nacional 0.558713	CLICK HERE
2055	National Cancer Institute	Html	es	Obesidad y cáncer	Hoja informativa que resume la evidencia que relaciona el sobrepeso y la obesidad al riesgo de cáncer.	body mass 0.350143 Cancer Research Fund 0.305964 Wang F 0.302675 IMC Categoría 0.303709 ligero aumento 0.313291 anthropometric factors 0.304184 pooled analysis from 0.302634 Wang X 0.302352 observational studies 0.307777 male breast 0.30286 risk factors 0.317009 Kitahara CM 0.305306 to modifiable factors 0.302578 ovarian cancer 0.313319 Estados Unidos 0.306361 mechanisms linking obesity 0.302489 PubMed Abstract 0.981157 Women's Health Initiative 0.305794 obesity prevalence among 0.302851 endometrial cancer 0.302426 Clinical Oncology 0.31976 obesidad causa 0.307215 prospective observational studies 0.307481 International Journal 0.314669 gallbladder cancer 0.310353	body size throughout 0.303222 United States 0.304211 Renehan AG 0.302352 Body Fatness 0.302339 mayores riesgos 0.303903 hormonal risk factors 0.304977 dose-response meta-analysis 0.303474 Cancer Research 0.314608 PLoS Medicine 0.303294 epidemiological studies 0.304197 Cancer Prevention Trial 0.306279 Current Oncology Reports 0.302446 different risk factors 0.304931 systematic review 0.305695 Annual Review 0.302768 risk according 0.303418 Excess body weight 0.303071 physical activity 0.302433 pooled analysis 0.316054 Cancer Institute 0.315531 lymphedema risk factors 0.304822 JAMA Oncology 0.304192 prospective studies 0.331726 New England Journal 0.306423	CLICK HERE
16381	National Cancer Institute	Html	es	Características genómicas de los cánceres infantiles (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las características genómicas de los cánceres infantiles. En este sumario se describen los subtipos moleculares de tipos específicos de cáncer infantil y las características clínicas relacionadas, las alteraciones genómicas recurrentes que caracterizan cada subtipo en el momento del diagnóstico o recidiva, y la importancia terapéutica y pronóstica de estas alteraciones. Se tratan las alteraciones genómicas relacionadas con tumores de encéfalo, tumores de riñón, leucemias, linfomas y otros tipos de cáncer.	frecuencia mutaciones 0.528888 genes mll 0.472072 Pediatric Acute Myeloid 0.497416 fusión npm-alk 0.439451 gen runx1t1 0.441044 North America 0.442782 IKZF1Las deleciones 0.453665 Sin embargo 0.617309 Katherine Tarlock 0.44723 mutaciones h3.3 0.551025 necesarias mutaciones 0.521725 secuencias codificadoras gfi1 0.437106 LLA hiperdiploide 0.80788 fusión il3-igh 0.467917 subtipo fab 0.455149 Ampliar Figura 0.451303 Pediatric Clinics 0.456212 Soheil Meshinchi 0.449095 gen etv6 0.449542 principales genes 0.447125 Otro gen 0.448963 GFI1 family oncogenes 0.435878 alteraciones genómicas tipo 0.497294 Genomic Variants 0.448917 gen mll 0.771285	células madre 0.513259 recaídas tardías 0.468538 leucemia linfoblástica aguda 0.548223 fusión bcr-abl1 0.481925 tipo ii 0.523537 gen runx1 0.541242 fusión etv6-runx1 0.484276 cromosoma filadelfia 0.948411 Acute Myeloid Leukemia 0.490135 valor pronóstico adverso 0.452162 Acute Lymphoblastic Leukemia 0.435296 células leucémicas hiperdiploides 0.488327 gen cbf-beta 0.443623 Age Group 0.442656 cromosomas hiperdiploidía 0.455258 Predisposition Genes 0.44826 fusión tcf3-hlf 0.515862 mutaciones activadoras 0.657624 Pediatric Oncology Group 0.437603 Therapeutic Implications 0.450243 genes jak 0.448326 Oncology Group 0.451583 subtipo fab m2 0.437855 determinados cánceres 0.434561	CLICK HERE
16696	National Cancer Institute	Html	en	Understanding Cervical Changes: A Health Guide for Women	Explains abnormal Pap test, HPV test, and Pap/HPV cotest results. Treatment and follow-up care for abnormal cervical cancer screening results including ASC-US, AGC, LSIL, ASC-H, HSIL, AIS. Learn about colposcopy, types of biopsies, CIN, and HPV vaccine.	cervical screening test 0.296143 cervical cancer cells 0.337703 health care provider 0.931179 cause cervical cancer 0.303315 abnormal cervical changes 0.298611 HPV types 0.331542 hpv infections 0.33479 abnormal cervical cell 0.295805 different HPV test 0.298266 cervical screening tests 0.300727 cervical cells 0.440061 HPV test work 0.298659 test results 0.460749 abnormal cervical screening 0.340129 HPV test 0.548179 cervical cancer screening 0.419584 HPV test result 0.334901 pap test 0.669223 cervical cancer 0.659605 abnormal test result 0.292044 high-risk hpv types 0.317446 HPV test results 0.312992 high-risk HPV infection 0.300301 women 0.2963	treatment 0.297209 abnormal cervical cells 0.352195 HPV vaccination 0.281435 Follow-Up Testing section 0.335149 HPV vaccine 0.303379 routine HPV testing 0.291048 HPV 0.555747 Pap test result 0.316098 Low-risk HPV types 0.299422 cervical cell changes 0.36625 Cervical screening recommendations 0.28727 abnormal pap test 0.394575 abnormal cervical cancer 0.33209 HPV vaccine series 0.282155 Normal Pap test 0.282878 Unsatisfactory Pap test 0.281328 Possible next steps 0.307487 common abnormal Pap 0.287706 HPV tests 0.293108 pap test results 0.389844 HPV infection 0.355986 abnormal cervical tissue 0.293862 recent abnormal Pap 0.289466 Cervical Cancer Treatment 0.291973	CLICK HERE
16835	National Cancer Institute	Html	en	Northwestern University — Cancer Nanotechnology Training Program	The focus of the Northwestern University Cancer Nanotechnology Training Center is presented here.	biological properties 0.685837 NU CCNE 0.813714 trainees 0.492664 Objectives 0.460665 cancer nanomaterials 0.715227 Ph.D 0.461621 tools 0.451616 basic courses 0.711616 research-based experiences 0.739642 skills 0.492332 career development programs 0.972187 MD 0.452108 PhD-level investigators 0.739449 centers 0.44872 National Cancer Institute 0.928332 Principal Investigator 0.787408 translational research 0.758394	clinical oncology 0.731649 International Institute 0.698015 needs 0.449442 Faculty 0.448884 Northwestern CNTC website 0.922154 Gayle Woloschak 0.790491 cancer patients 0.717775 eventual goal 0.748956 BioNanotechnology 0.51845 well-rounded curriculum 0.761183 efficacy 0.474176 nanotechnology resources 0.803175 principles 0.451682 Training Focus 0.735308 cancer biology 0.721666 training program 0.906256	CLICK HERE
17287	National Cancer Institute	Html	es	Búsqueda de servicios médicos	Sugerencias para elegir a un doctor o un establecimiento de tratamiento, opciones de cuidados médicos, atención a domicilio y cuidados para pacientes terminales.	teléfono al ACoS 0.406963 practicantes miembros 0.405783 línea quality check 0.40869 es el doctor 0.42878 Asociación Estadounidense 0.423296 usa rayos 0.406918 cirujanos miembros 0.406162 cuenta los costos 0.406987 capacitación de residencia 0.407585 Atención Médica Asequible 0.412098 Especialistas Médicos 0.407972 la asociación médica estadounidense 0.414538 información sobre cobertura 0.405498 International Cancer Control 0.40739	Colegio Estadounidense 0.438106 seguro médico 0.61246 Seguros Médicos 0.413052 Oncología Clínica 0.406552 pagar el tratamiento 0.41398 paciente satisface los requisitos 0.408803 Comisión Conjunta 0.429316 Oncólogo radiólogo 0.407999 los estados unidos 0.40683 atención médica 0.448896 Estados Unidos 0.919617 información a disposición 0.40585 cuestiones de viaje 0.405374	CLICK HERE